Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.3.4) and removes the prior revision (v3.3.3). This is a log-level update to the history and does not modify the study data.
    Difference
    0.1%
    Check dated 2026-01-14T04:10:56.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T23:06:39.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page history shows an added revision (v3.3.2) and a removed revision (v3.2.0); this reflects a UI/system update with no substantive changes to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:22.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed a government funding/operating status notice from the page, a minor administrative update that does not affect study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T07:17:22.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The new screenshot adds an extra version entry to the record history and shows minor UI tweaks; the primary study information and history structure remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T21:24:21.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Summary of changes: added a government-operating-status notice and new v3.2.0 version tag; removed the old v3.1.0 tag. The page now communicates current funding-related limitations and where to check status, marking a conduction of a software/website update.
    Difference
    11%
    Check dated 2025-10-06T06:58:40.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.